EUVIMEDEUVIMED entdecken
CrossrefInfokarte

5‐HT‐Uptake Inhibition Potentiates Antinociception Induced by Morphine, Pethidine, Methadone and Ketobemidone in Rats

Jens-Jørgen Larsen, John Hyttel

Acta Pharmacologica et Toxicologica · 1985

DOI: 10.1111/bcpt.1985.57.3.214 ↗
AbstractBibliografische Angaben

Abstract

The effect of the specific 5‐HT‐uptake inhibitor citalopram on the antinociception induced by morphine, pethidine, methadone and ketobemidone was examined in rats by means of the hot plate test. Further the 5‐HT‐uptake‐inhibiting potency of these opioid‐receptor stimulants was examined in vitro in rat brain synaptosomes. In doses devoid of antinociceptive activity, citalopram in a dose‐dependent manner potentiated the antinociception induced by the four opioid analgesics. The potentiation of the ketobemidone‐induced antinociception was not influenced by the spasmolytic agent A 29 (N,N‐dimethyl‐3,3‐diphenyl‐l‐methylallylamine) which together with ketobemidone constitutes the active substances in Ketogan®. The 5‐HT‐uptake‐inhibiting potencies of the opioid receptor stimulants were from 21 to more than 56000 times lower than that of citalopram, the order of potency being methadone> pethidine> ketobemidone > morphine. The results support the suggested role of 5‐HT in morphine‐induced antinociception and indicate a similar role in the antinociceptive effect induced by other opioid‐receptor stimulants.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →